First-in-human, phase 1, open-label study of alomfilimab, an anti-ICOS antibody, as a single agent and in combination with anti-PD-L1 in advanced malignancies. [PDF]
Naing A +15 more
europepmc +1 more source
Building evidence on digital psychotherapies for adults living with depression: a systematic scoping review of populations, interventions and design features of ongoing and planned randomised controlled trials. [PDF]
Duranté EK +5 more
europepmc +1 more source
Activation of tumor-specific CD8+ T cells prior to radiopharmaceutical therapy improves antitumor response. [PDF]
Shim D +8 more
europepmc +1 more source
Exploring the acceptability of a brief, rapid-access, self-harm focussed talking therapy: a qualitative analysis of patient experiences. [PDF]
Clements C +9 more
europepmc +1 more source
Impact of COVID-19 pandemic on autism spectrum disorder service providers in Qatar: challenges, insights, and lessons learned. [PDF]
Alshaban F +9 more
europepmc +1 more source
"Therapy Beyond the Screen": A Qualitative Exploration of Tele-Therapy Experiences Among Clinical Psychologists and Speech and Language Therapists. [PDF]
Yaşa İC +5 more
europepmc +1 more source
The moderating and mediating effects of mindful compassion with body-mind-spirit therapy using a blended approach of face-to-face with online for breast cancer patients' depression during COVID-19: A randomized controlled trial. [PDF]
Hsiao FH +4 more
europepmc +1 more source
RETRACTION: Antileukotriene Therapy by Reducing Tau Phosphorylation Improves Synaptic Integrity and Cognition of P301S Transgenic Mice. [PDF]
europepmc +1 more source

